Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
Italy Diabetes Drugs and Devices Market Introduction and Overview
According to SPER market research, ‘Italy Diabetes Drugs and Devices Market Size- By Management Devices, By Monitoring Devices – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’state that the Italy Diabetes Drugs and Devices Market is predicted to reach USD 1.85 billion by 2033 with a CAGR of 6.31%.
A variety of pharmaceuticals and medical equipment together referred to as diabetes drugs and devices are used to control and treat diabetes mellitus, a chronic metabolic condition characterized by elevated blood sugar levels. Insulin, oral hypoglycemic medications, and injectable blood glucose-regulating therapies make up the pharmacological component.
The COVID-19 epidemic in Italy has significantly harmed diabetic care equipment. The epidemic brought to light opportunities for creating and extending diabetic care delivery. These included online consultations between diabetics and medical professionals as well as the use of diabetes technologies. hanks to crisis management, a number of long-standing regulatory restrictions have been loosened, and patients and doctors are now requesting remote care at a never-before-seen degree.
Scope of the Report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Management Devices, By Monitoring Devices
Regions covered Eastern Region, Western Region, Northern Region, Southern Region
Companies Covered
Abbott Diabetes Care, Arkray Inc., Ascensia Diabetes Care, Dexcom, Insulet Corporation, Eli Lilly, LifeScan Inc., Medtronic, Novo Nordisk A/S, Roche Diabetes Care, Rossmax International Ltd., Sanofi.
Italy Diabetes Drugs and Devices Market Segmentation:
By Management Devices: Based on the Management Devices, Italy Diabetes Drugs and Devices Market is segmented as; Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors.
By Monitoring Devices: Based on the Monitoring Devices, Italy Diabetes Drugs and Devices Market is segmented as; Self-Monitoring Devices, Continuous Glucose Monitoring.
By Region:This research also includes data for Eastern Region, Western Region, Southern Region, Northern Region.
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER’s internal database
- 2.1.4. Premium insight from KOL’s
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Italy Diabetes Drugs and Devices Market
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER’s Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Italy Diabetes Drugs and Devices Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Italy Diabetes Drugs and Devices Market
- 7. Italy Diabetes Drugs and Devices Market, By Management Devices (USD Million) 2020-2033
- 7.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2020-2026
- 7.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2027-2033
- 7.3. Insulin Pump
- 7.3.1. Insulin Pump device
- 7.3.2. Insulin Pump Reservoir
- 7.3.3. Infusion Set
- 7.4. Insulin Syringes
- 7.5. Cartridges in Reusable Pens
- 7.6. Insulin Disposable Pens
- 7.7. Jet Injectors
- 8. Italy Diabetes Drugs and Devices Market, By Monitoring Devices (USD Million) 2020-2033
- 8.1. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2020-2026
- 8.2. Italy Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2027-2033
- 8.3. Self-Monitoring Devices
- 8.3.1. Glucometer Devices
- 8.3.2. Blood Glucose Test Strips
- 8.3.3. Lancets
- 8.4. Continuous Glucose Monitoring
- 8.4.1. Sensors
- 8.4.2. Durables
- 9. Italy Diabetes Drugs and Devices Market Forecast, 2020-2033 (USD Million)
- 9.1. Italy Diabetes Drugs and Devices Market Size and Market Share
- 10. Italy Diabetes Drugs and Devices Market, By Region, 2020-2033 (USD Million)
- 10.1. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2020-2026)
- 10.2. Italy Diabetes Drugs and Devices Market Size and Market Share By Region (2027-2033)
- 10.3. Eastern Region
- 10.4. Northern Region
- 10.5. Eastern Region
- 10.6. Western Region
- 11. Company Profile
- 11.1. Abbott Diabetes Care
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
- 11.2. Arkray Inc.
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
- 11.3. Ascensia Diabetes Care
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
- 11.4. Dexcom
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
- 11.5. Insulet Corporation
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
- 11.6. Eli Lilly
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
- 11.7. LifeScan Inc.
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
- 11.8. Medtronic
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
- 11.9. Novo Nordisk A/S
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
- 11.10. Roche Diabetes Care
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
- 11.11. Rossmax International Ltd.
- 11.11.1. Company details
- 11.11.2. Financial outlook
- 11.11.3. Product summary
- 11.11.4. Recent developments
- 11.12. Sanofi
- 11.12.1. Company details
- 11.12.2. Financial outlook
- 11.12.3. Product summary
- 11.12.4. Recent developments
- 11.13. Others
- 12. Conclusion
- 13. Reference Links
- 14. List of Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook